Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Calcium and vitamin D supplementation appeared to attenuate but not eliminate the adverse effects, with supplemented patients showing smaller but still significant differences in bone loss compared to unsupplemented intranasal corticosteroid users (interaction p = 0.089).
Source: Subgroup analyses. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study
Source: Article title.
Participants were categorized into INCS (n = 198), second-generation antihistamine (sgAH, n = 187), combination therapy (n = 156), and control (n = 150) groups.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Long-term intranasal corticosteroids vs. antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study
Cohort study · Frontiers in Medicine · 2026
Original publication title
Long-term intranasal corticosteroids vs. antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study
Copyright © 2026 Jia, Liu and Yang.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Intranasal corticosteroids (INCS) are first-line therapy for allergic rhinitis (AR), but their long-term skeletal safety in post-menopausal women: who are inherently vulnerable to bone loss: remains inadequately studied despite low systemic bioavailability.
Source: BackgroundAbstract: What methods does the paper describe?
This retrospective cohort study included 691 post-menopausal women with persistent AR treated from 2015 to 2023. Participants were categorized into INCS (n = 198), second-generation antihistamine (sgAH, n = 187), combination therapy (n = 156), and control (n = 150) groups. Primary outcomes were changes in bone mineral density (BMD) T-scores and incident osteoporosis. Secondary outcomes included fragility fractures. Multivariable regression analyses were performed with adjustment for confounders, and dose-response relationships were evaluated using defined daily doses.
Source: MethodsAbstract: Results
Over a median follow-up of 4.2 years, INCS users exhibited significantly greater declines in lumbar spine T-scores compared to controls, with similar findings at the femoral neck. sgAH users showed no significant bone loss. Dose-response analysis revealed linear trends for greater bone loss with higher cumulative INCS exposure. Incident osteoporosis occurred in 24.2% of INCS users vs. 11.3% of controls. Fragility fracture rates were highest in the INCS group with adjusted HR 3.85 (95% CI = 1.45 to 10.24, p = 0.007) vs. controls. sgAH showed no increased fracture risk (HR 1.13, 95% CI = 0.33 to 3.89).
Subgroup analyses identified heightened risk in women aged ≥65 years and those with BMI < 23 kg/m2.
Source: ResultsAbstract: Conclusions
Long-term INCS use in post-menopausal women was associated with accelerated bone loss, increased osteoporosis risk, and higher fracture rates in a dose-dependent manner. These findings raise concerns regarding the assumption of complete INCS skeletal safety in post-menopausal women and suggest the need for enhanced bone monitoring in this population.
Source: ConclusionsAuthors’ abstract
Background
Intranasal corticosteroids (INCS) are first-line therapy for allergic rhinitis (AR), but their long-term skeletal safety in post-menopausal women: who are inherently vulnerable to bone loss: remains inadequately studied despite low systemic bioavailability.
Methods
This retrospective cohort study included 691 post-menopausal women with persistent AR treated from 2015 to 2023. Participants were categorized into INCS (n = 198), second-generation antihistamine (sgAH, n = 187), combination therapy (n = 156), and control (n = 150) groups. Primary outcomes were changes in bone mineral density (BMD) T-scores and incident osteoporosis. Secondary outcomes included fragility fractures. Multivariable regression analyses were performed with adjustment for confounders, and dose-response relationships were evaluated using defined daily doses.
Results
Over a median follow-up of 4.2 years, INCS users exhibited significantly greater declines in lumbar spine T-scores compared to controls, with similar findings at the femoral neck. sgAH users showed no significant bone loss. Dose-response analysis revealed linear trends for greater bone loss with higher cumulative INCS exposure. Incident osteoporosis occurred in 24.2% of INCS users vs. 11.3% of controls. Fragility fracture rates were highest in the INCS group with adjusted HR 3.85 (95% CI = 1.45 to 10.24, p = 0.007) vs. controls. sgAH showed no increased fracture risk (HR 1.13, 95% CI = 0.33 to 3.89).
Subgroup analyses identified heightened risk in women aged ≥65 years and those with BMI < 23 kg/m2.
Conclusions
Long-term INCS use in post-menopausal women was associated with accelerated bone loss, increased osteoporosis risk, and higher fracture rates in a dose-dependent manner. These findings raise concerns regarding the assumption of complete INCS skeletal safety in post-menopausal women and suggest the need for enhanced bone monitoring in this population.
Publication and source details
Original title: Long-term intranasal corticosteroids vs. antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study
Xiaofei Jia; Lei Liu; Yanzhong Yang
Frontiers in Medicine · 2026
* Correspondence: Xiaofei Jia, eyjxffei@163.comCopyright © 2026 Jia, Liu and Yang.2026Jia, Liu and Yanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:56:43.742079+00:00
DOI: 10.3389/fmed.2026.1838641 · PMC13500620